Ku-Chou Chang Selected Research

Ku-Chou Chang Research Topics

37	Stroke (Strokes) 01/2022 - 07/2002
15	Ischemic Stroke 12/2019 - 11/2002
5	Cognitive Dysfunction 01/2022 - 10/2016
3	Pathologic Constriction (Stenosis) 12/2016 - 01/2005
2	Muscle Spasticity (Spastic) 01/2022 - 01/2021
2	Diabetes Mellitus 05/2005 - 04/2004
2	Cerebral Infarction 04/2004 - 01/2004
1	Sleep Deprivation 01/2020
1	Neurologic Manifestations (Neurological Manifestations) 11/2017
1	Infarction (Infarctions) 10/2017
1	Intracranial Hemorrhages (Intracranial Hemorrhage) 12/2016
1	Papillary Thyroid Cancer 03/2016
1	Heart Diseases (Heart Disease) 01/2016
1	Hemorrhagic Stroke 01/2016
1	Myocardial Infarction 12/2014
1	Cerebrovascular Disorders (Cerebrovascular Occlusion) 01/2014
1	Cerebral Hemorrhage 11/2013
1	Hemorrhage 10/2010
1	Thrombosis (Thrombus) 10/2010
1	Aspiration Pneumonia 03/2008
1	Infections 03/2008
1	Deglutition Disorders (Dysphagia) 03/2008
1	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 05/2006
1	Hyperoxia 05/2006
1	Atrial Fibrillation 05/2006
1	Hyperglycemia 05/2005
1	Atherosclerosis 01/2005
1	Meningitis 06/2004
1	Insulin Resistance 04/2004
1	Cardiovascular Diseases (Cardiovascular Disease) 04/2004

4	Tissue Plasminogen Activator (Alteplase)FDA Link 10/2017 - 03/2004
3	incobotulinumtoxinA FDA Link 01/2022 - 01/2021
3	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 09/2015 - 06/2006
2	Type A Botulinum Toxins (Botox)FDA Link 12/2021 - 01/2021
2	Desmodus rotundus salivary plasminogen activator alpha 1IBA 12/2016 - 06/2015
2	danaparoid (Orgaran)FDA Link 01/2016 - 01/2005
2	Mitochondrial DNA (mtDNA)IBA 05/2005 - 04/2004
2	NucleotidesIBA 05/2005 - 04/2004
1	Botulinum Toxins (Botulinum Toxin)IBA 01/2022
1	Coffee FDA Link 01/2020
1	TeaIBA 01/2020
1	Fibrinolytic Agents (Antithrombotic Agents)IBA 12/2019
1	Therapeutic UsesIBA 10/2019
1	N 30IBA 01/2019
1	Biomarkers (Surrogate Marker)IBA 03/2018
1	Biological ProductsIBA 11/2017
1	SaltsIBA 11/2017
1	MagnesiumIBA 11/2017
1	PotassiumIBA 11/2017
1	C-Reactive ProteinIBA 10/2017
1	P-2 (P 2)IBA 03/2016
1	CreatinineIBA 01/2016
1	FibrinIBA 06/2015
1	Plasminogen Activators (Plasminogen Activator)IBA 06/2015
1	Clopidogrel (Plavix)FDA Link 12/2014
1	omega-Chloroacetophenone (Mace)IBA 12/2014
1	AlbuminsIBA 01/2012
1	Hemoglobins (Hemoglobin)IBA 01/2012
1	OF 900IBA 10/2010
1	Heparin (Liquaemin)FDA LinkGeneric 10/2010
1	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 10/2010
1	LipidsIBA 11/2007
1	ORALIT (ORS)IBA 11/2006
1	Propylthiouracil FDA Link 06/2006
1	Oxygen (Dioxygen)IBA 05/2006
1	Free RadicalsIBA 05/2005
1	Anti-Bacterial Agents (Antibiotics)IBA 06/2004
1	Insulin (Novolin)FDA Link 04/2004
1	Blood Glucose (Blood Sugar)IBA 04/2004
1	A 17 (A-17)IBA 01/2004

11	Therapeutics 01/2022 - 01/2004
5	Cognitive Training 01/2022 - 10/2016
2	Mirror Movement Therapy 01/2022 - 12/2018
2	Activities of Daily Living (ADL) 01/2022 - 03/2008
2	Thrombolytic Therapy 06/2015 - 03/2004
2	Length of Stay 03/2008 - 11/2002
1	Thrombectomy 03/2021
1	Injections 01/2021
1	Psychology Biofeedback (Biofeedback) 10/2016
1	Critical Care (Surgical Intensive Care) 01/2016
1	Chinese Traditional Medicine (Traditional Chinese Medicine) 01/2014
1	Subacute Care 01/2014
1	Acupuncture Therapy 01/2011
1	Speech Therapy (Therapy, Speech) 03/2010
1	Stroke Rehabilitation 03/2010
1	Physical Therapy Modalities (Physical Therapy Technique) 03/2010
1	Occupational Therapy (Therapy, Occupational) 03/2010
1	Aftercare (After-Treatment) 06/2006
1	Cannula 05/2006
1	First Aid (Aids, First) 07/2002